• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左主干病变患者冠状动脉搭桥术与经皮冠状动脉介入治疗的早期及长期预后:多学科决策的单中心结果

Early and long-term outcomes of coronary artery bypass grafting and percutaneous coronary intervention in patients with left main disease: single-center results of multidisciplinary decision making.

作者信息

Fukui Toshihiro, Tabata Minoru, Tobaru Tetsuya, Asano Ryuta, Takanashi Shuichiro, Sumiyoshi Tetsuya

机构信息

Department of Cardiovascular Surgery, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Fuchu, Tokyo, 183-0003, Japan,

出版信息

Gen Thorac Cardiovasc Surg. 2014 May;62(5):301-7. doi: 10.1007/s11748-013-0357-7. Epub 2013 Dec 8.

DOI:10.1007/s11748-013-0357-7
PMID:24317798
Abstract

OBJECTIVE

Coronary artery bypass grafting (CABG) is considered the standard treatment for patients with left main disease (LMD). However, percutaneous coronary intervention (PCI) has recently emerged as a treatment option for selected patients. We assessed early and long-term outcomes of patients with LMD who underwent either CABG or PCI in our institution.

METHODS

We reviewed the records of 438 patients with LMD who underwent revascularization between January 2005 and December 2010. Treatment modality, chosen by our heart team, was CABG in 409 patients and PCI in 29. Age, prevalence of women, and mean ejection fraction of patients were not significantly different between groups. Mean logistic European system for cardiac operative risk evaluation score was 7.7. Mean follow-up was 37.1 months.

RESULTS

In CABG group, mean number of anastomoses was 4.0 and complete revascularization was achieved in 97.1 %. Bilateral internal thoracic arteries were used in 87.0 %. In PCI group, mean number of stents was 1.3 and complete revascularization was achieved in 44.8 %. Drug-eluting stent was used in 72.4 %. In-hospital mortality was 1.1 % (1.0 %, CABG group vs. 3.4 %, PCI group; p = 0.29). At 3 years, overall survival was 94.3 % (95.3 vs. 81.1 %; p < 0.01) and rate of freedom from major adverse cardiac events and cerebrovascular accidents was 88.9 % (89.8 vs. 77.3 %; p = 0.05).

CONCLUSIONS

Our heart team's approach resulted in favorable overall results in patients with LMD. Multidisciplinary decision making in these high-risk patients can make good long-term outcomes in CABG.

摘要

目的

冠状动脉旁路移植术(CABG)被认为是左主干病变(LMD)患者的标准治疗方法。然而,经皮冠状动脉介入治疗(PCI)最近已成为部分患者的治疗选择。我们评估了在我院接受CABG或PCI治疗的LMD患者的早期和长期预后。

方法

我们回顾了2005年1月至2010年12月期间438例接受血运重建的LMD患者的记录。由我们的心脏团队选择的治疗方式为,409例患者接受CABG,29例患者接受PCI。两组患者的年龄、女性患病率和平均射血分数无显著差异。平均逻辑欧洲心脏手术风险评估系统评分为7.7。平均随访时间为37.1个月。

结果

在CABG组中,平均吻合口数量为4.0个,97.1%的患者实现了完全血运重建。87.0%的患者使用了双侧胸廓内动脉。在PCI组中,平均支架数量为1.3个,44.8%的患者实现了完全血运重建。72.4%的患者使用了药物洗脱支架。住院死亡率为1.1%(CABG组为1.0%,PCI组为3.4%;p = 0.29)。3年时,总体生存率为94.3%(95.3%对8

相似文献

1
Early and long-term outcomes of coronary artery bypass grafting and percutaneous coronary intervention in patients with left main disease: single-center results of multidisciplinary decision making.左主干病变患者冠状动脉搭桥术与经皮冠状动脉介入治疗的早期及长期预后:多学科决策的单中心结果
Gen Thorac Cardiovasc Surg. 2014 May;62(5):301-7. doi: 10.1007/s11748-013-0357-7. Epub 2013 Dec 8.
2
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
3
Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.药物洗脱支架与冠状动脉旁路移植术治疗左主干病变的 10 年结果:PRECOMBAT 试验的扩展随访。
Circulation. 2020 May 5;141(18):1437-1446. doi: 10.1161/CIRCULATIONAHA.120.046039. Epub 2020 Mar 30.
4
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
5
Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.左主干冠状动脉疾病血运重建术根据 SYNTAX 评分。
Circ Cardiovasc Interv. 2019 Sep;12(9):e008007. doi: 10.1161/CIRCINTERVENTIONS.118.008007. Epub 2019 Sep 9.
6
Everolimus-eluting stents or bypass surgery for multivessel coronary disease.依维莫司洗脱支架或旁路手术治疗多支冠状动脉疾病。
N Engl J Med. 2015 Mar 26;372(13):1213-22. doi: 10.1056/NEJMoa1412168. Epub 2015 Mar 16.
7
Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.多动脉旁路移植可改善多支血管病变患者冠状动脉血运重建术后早期主要心脏和脑血管不良事件的发生率:12615 例患者分析。
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):746-752. doi: 10.1093/ejcts/ezx171.
8
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干或多支冠状动脉疾病:一项个体患者数据的荟萃分析。
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
9
Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.新一代药物洗脱支架与冠状动脉旁路移植术治疗多支和/或左主干冠状动脉疾病的长期结局:随机对照试验的贝叶斯网络荟萃分析
Cardiovasc Revasc Med. 2018 Sep;19(6):671-678. doi: 10.1016/j.carrev.2018.01.003. Epub 2018 Jan 5.
10
Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients.在真实世界中患有多支冠状动脉疾病(包括左主干疾病)的患者中,冠状动脉旁路移植术相较于新一代支架的经皮冠状动脉介入治疗可带来中期生存获益:一项回顾性分析纳入了 6383 例患者。
Eur J Cardiothorac Surg. 2019 Nov 1;56(5):911-918. doi: 10.1093/ejcts/ezz142.

引用本文的文献

1
A Systematic Review and Meta-Analysis of 35,409 Patients Undergoing PCI CABG for Unprotected Left Main Coronary Artery Diseases.对35409例接受经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)的无保护左主干冠状动脉疾病患者的系统评价和荟萃分析。
Rev Cardiovasc Med. 2024 Aug 9;25(8):282. doi: 10.31083/j.rcm2508282. eCollection 2024 Aug.
2
Acute Coronary Syndrome Does Not Have a Negative Impact on Outcomes after Coronary Artery Bypass Grafting in Patients with Left Main Disease.急性冠状动脉综合征对左主干病变患者冠状动脉旁路移植术后的预后无负面影响。
Ann Thorac Cardiovasc Surg. 2015;21(3):261-7. doi: 10.5761/atcs.oa.14-00228. Epub 2015 Jan 26.

本文引用的文献

1
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗在三支病变合并左主干病变患者中的比较:随机、临床 SYNTAX 试验的 5 年随访结果。
Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.
2
Rotational atherectomy followed by cutting-balloon plaque modification for drug-eluting stent implantation in calcified coronary lesions.在钙化冠状动脉病变中,先进行旋磨术,然后采用切割球囊斑块修饰术以植入药物洗脱支架。
J Invasive Cardiol. 2012 May;24(5):191-5.
3
Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of early outcomes from randomized and nonrandomized studies.
药物洗脱支架与冠状动脉旁路移植术治疗左主干冠状动脉疾病:随机和非随机研究早期结果的荟萃分析。
J Thorac Cardiovasc Surg. 2013 Mar;145(3):738-47. doi: 10.1016/j.jtcvs.2012.02.004. Epub 2012 Mar 9.
4
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植手术指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 6;124(23):2610-42. doi: 10.1161/CIR.0b013e31823b5fee. Epub 2011 Nov 7.
5
Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).比较经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干冠状动脉疾病伴急性冠状动脉综合征患者的一年预后(来自 CUSTOMIZE 注册研究)。
Am J Cardiol. 2011 Aug 1;108(3):355-9. doi: 10.1016/j.amjcard.2011.03.050. Epub 2011 May 3.
6
Randomized trial of stents versus bypass surgery for left main coronary artery disease.左主干冠状动脉疾病支架与旁路手术的随机试验。
N Engl J Med. 2011 May 5;364(18):1718-27. doi: 10.1056/NEJMoa1100452. Epub 2011 Apr 4.
7
Guidelines on myocardial revascularization.心肌血运重建指南。
Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277. Epub 2010 Aug 29.
8
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.在 Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery(SYNTAX)试验中,经皮冠状动脉介入治疗使用紫杉醇洗脱支架或冠状动脉旁路移植术治疗新发左主干疾病患者的结局。
Circulation. 2010 Jun 22;121(24):2645-53. doi: 10.1161/CIRCULATIONAHA.109.899211. Epub 2010 Jun 7.
9
Unprotected left main revascularization in patients with acute coronary syndromes.急性冠状动脉综合征患者的非保护左主干血运重建。
Eur Heart J. 2009 Oct;30(19):2308-17. doi: 10.1093/eurheartj/ehp353. Epub 2009 Aug 30.
10
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗严重冠状动脉疾病的比较
N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18.